Laurus Labs Share Price
Mid Cap | Pharmaceuticals and health care | NSE: LAURUSLABS | BSE: 540222
₹574.45 -46.20 (-7.44 %)
Last Updated: 04 Apr 2025 03:58 PM
Overview
Open (₹) 620.65
High (₹) 621.80
Low (₹) 561.50
Prev. Close (₹) 620.65
Volume 72,86,180
VWAP (₹) 529.66
ROCE (%) 7.94
Industry P/E 46.49
TTM P/E 154.84
P/B Ratio 7.52
Market Cap (₹) Cr.30,977.36
Dividend Yield (%)0.14
EPS (₹) 2.97
ROE3.89%
Sales Growth (%) -16.55
Profit Growth (%)-78.89
Day Range
621.80621.80
52 Week Range
386.85646.25
Historical Returns
Returns (6M)
33.19 %
Returns (1Y)
31.33 %
Returns (3Y)
-5.6 %
Returns (5Y)
632.06 %
Returns (6M)
33.19 %
Returns (1Y)
31.33 %
Returns (3Y)
-5.6 %
Returns (5Y)
632.06 %
SWOT Analysis
- Book value per share improving over the last 2 years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 38.78
MFI 23.57
ATR 28.12
Commodity Channel Index -89.28
ROC125 15.16
ROC21 -10.41
Williams %R -88.35
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 535.89 | 544.57 | 551.24 | 529.22 | 520.54 | 513.87 | 505.19 |
Week Ago | 535.94 | 550.42 | 559.39 | 526.97 | 512.49 | 503.52 | 489.04 |
Month Ago | 530.66 | 550.58 | 563.66 | 517.58 | 497.66 | 484.58 | 464.66 |
EMA & SMA
574.45
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
5
5 Day 530.96
9 Day 543.41
10 Day 541.93
12 Day 562.93
14 Day 569.24
20 Day 579.21
26 Day 575.76
50 Day 577.25
100 Day 540.90
200 Day 496.35
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 27 Jan, 2025 | ₹536.23 | 36,89,009 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 27 Jan, 2025 | ₹536.50 | 36,90,709 | NSE |
CYBAGE SOFTWARE PRIVATE LIMITED | block | Sell | 14 Mar, 2023 | ₹305.00 | 6,35,894 | NSE |
ARUN VIJAY NATHANI | block | Buy | 14 Mar, 2023 | ₹305.00 | 6,35,894 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 14 Nov, 2022 | ₹455.40 | 5,29,337 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 14 Nov, 2022 | ₹455.40 | 5,29,337 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Nov, 2022 | ₹476.60 | 5,29,338 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Nov, 2022 | ₹476.60 | 5,29,338 | NSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹513.00 | 68,448 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹513.00 | 4,37,878 | NSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹513.00 | 68,448 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹513.00 | 4,37,878 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 03 Aug, 2020 | ₹1,011.48 | 6,43,600 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 03 Aug, 2020 | ₹1,011.41 | 6,43,600 | NSE |
SETU SECURITIES PVT LTD | bulk | Sell | 29 Jun, 2020 | ₹512.06 | 15,72,343 | NSE |
MILLENNIUM STOCK BROKING PVT LTD | bulk | Sell | 29 Jun, 2020 | ₹510.95 | 6,08,360 | NSE |
AVNI PARESH SHAH | bulk | Sell | 29 Jun, 2020 | ₹511.76 | 9,36,470 | NSE |
SETU SECURITIES PVT LTD | bulk | Buy | 29 Jun, 2020 | ₹519.76 | 50,317 | NSE |
MILLENNIUM STOCK BROKING PVT LTD | bulk | Buy | 29 Jun, 2020 | ₹513.21 | 52,448 | NSE |
AVNI PARESH SHAH | bulk | Buy | 29 Jun, 2020 | ₹513.30 | 52,341 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
10 Dec, 2024 | PRATHIMA CHAVA | Pledge | ₹576.40 | 2,00,000 | NSE |
30 Oct, 2023 | Mrs. G. Sreelakshmi | Disposal | ₹376.00 | 10,000 | NSE |
24 Mar, 2022 | Venkata Jayasree Kumari Tadikonda | Acquisition | ₹578.70 | 788 | NSE |
24 Mar, 2022 | Venkata Jayasree Kumari Tadikonda | Acquisition | ₹578.70 | 3,992 | NSE |
24 Mar, 2022 | Venkata Jayasree Kumari Tadikonda | Acquisition | ₹578.70 | 2,906 | NSE |
01 Mar, 2022 | MADHURI MEDASANI | Acquisition | ₹539.67 | 10,000 | NSE |
01 Mar, 2022 | YAMINI TANGUTURI | Disposal | ₹525.95 | 2,275 | NSE |
18 Dec, 2021 | CHANDRA KUMARI | Pledge | ₹505.00 | 10,245 | NSE |
20 Sept, 2021 | VIJAYA KUMARI SURYADEVARA | Disposal | ₹657.92 | 12,000 | NSE |
09 Sept, 2021 | SREELAKSHMI GOGIREDDY | Disposal | ₹650.90 | 4,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
24 Oct, 2024 | Rs.0.4000 per share(20%)Interim Dividend | 06 Nov, 2024 | 06 Nov, 2024 |
25 Apr, 2024 | Rs.0.4000 per share(20%)Interim Dividend | 08 May, 2024 | 08 May, 2024 |
20 Oct, 2023 | Rs.0.4000 per share(20%)Interim Dividend | 02 Nov, 2023 | 02 Nov, 2023 |
30 Apr, 2020 | Stock split from Rs. 10/- to Rs. 2/-. | 29 Sept, 2020 | 30 Sept, 2020 |
Announcements
Date | Source | Detail |
---|---|---|
28 Mar, 2025 | NSE India | Laurus Labs Limited has informed the Exchange regarding ''Corrigendum to Intimation of Grant of Stock Options to the eligible employees dated 28.03.2025''. |
28 Mar, 2025 | BSE India | Please see annexed enclosure. |
28 Mar, 2025 | BSE India | Please see annexed enclosure. |
28 Mar, 2025 | BSE India | Please see annexed enclosure. |
28 Mar, 2025 | NSE India | Laurus Labs Limited has informed the Exchange about acquisition |
28 Mar, 2025 | NSE India | Laurus Labs Limited has informed the Exchange about Intimation of re-appointment of Executive Directors of the Company |
28 Mar, 2025 | NSE India | Laurus Labs Limited has informed the Exchange about Intimation of Grant of Stock Options to the eligible employees |
28 Mar, 2025 | BSE India | Please see annexed enclosure. |
27 Mar, 2025 | NSE India | LAURUS LABS LIMITED has informed the Exchange about Closure of Trading Window |
27 Mar, 2025 | NSE India | Laurus Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 07 Jan, 2025 | 24 Jan, 2025 |
Quarterly Results & Interim Dividend | -- | 17 Oct, 2024 | 24 Oct, 2024 |
Quarterly Results | -- | 22 Jul, 2024 | 25 Jul, 2024 |
Audited Results & Interim Dividend | -- | 19 Apr, 2024 | 25 Apr, 2024 |
Quarterly Results | -- | 18 Jan, 2024 | 24 Jan, 2024 |
Quarterly Results & Interim Dividend | -- | 16 Oct, 2023 | 20 Oct, 2023 |
Quarterly Results | -- | 21 Jul, 2023 | 27 Jul, 2023 |
Audited Results & 2nd Interim Dividend | -- | 20 Apr, 2023 | 27 Apr, 2023 |
Quarterly Results | -- | 24 Jan, 2023 | 30 Jan, 2023 |
Quarterly Results & Interim Dividend | -- | 14 Oct, 2022 | 21 Oct, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 27.62% | 27.19% | 27.2% | 27.27% | 28.73% |
Foreign Institutions + | 25.56% | 25.39% | 21.9% | 22.06% | 19.92% |
Domestic Institutions + | 12.74% | 11.13% | 9.51% | 6.92% | 4.07% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 34.08% | 36.29% | 41.39% | 43.75% | 47.28% |
Others | 0% | 0% | 0% | 0% | 0% |
About Laurus Labs
Laurus Labs is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 4812.39 Cr. and Equity Capital is Rs. 107.79 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2005
Managing Director
-- --
NSE Symbol
LAURUSLABS
Laurus Labs Management
Name | Designation |
---|---|
Dr. Ravindranath Kancherla | Non Exe.Chairman&Ind.Director |
Mr. V V Ravi Kumar | Executive Director & CFO |
Dr. Satyanarayana Chava | Executive Director & CEO |
Dr. C V Lakshmana Rao | Executive Director |
Mr. Krishna Chaitanya Chava | Executive Director |
Ms. Soumya Chava | Executive Director |
Dr. Rajesh Koshy Chandy | Independent Director |
Mrs. Aruna Rajendra Bhinge | Independent Director |
Mr. Karnam Sekar | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Laurus Labs
What is the share price of Laurus Labs?
The share price of Laurus Labs on 04 Apr, 2025 is ₹ 574.45.
What is 52W high and 52W low share price of Laurus Labs?
The highest and lowest 52W share prices of Laurus Labs are ₹ 646.250 and ₹ 386.850
What is the market cap of Laurus Labs?
The market capitalization of Laurus Labs as of 04 Apr, 2025 is ₹ 30,977.36 Crores
What is the P/E ratio of Laurus Labs?
The current P/E ratio of Laurus Labs as of 04 Apr, 2025 is 46.49
What is the PB ratio of Laurus Labs?
The PB ratio of Laurus Labs as of 04 Apr, 2025 is 7.52
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)